Miami-based alternative investment firm H.I.G. Capital has made significant strategic moves in the North American market during February, highlighting the firm’s diversified approach across healthcare and growth equity sectors.

The $67 billion investment giant completed the sale of specialty healthcare provider Soleo Health while simultaneously earning recognition for its growth equity division, underscoring the firm’s multifaceted strategy in its home market.

Healthcare exit shows value creation formula

On February 3, H.I.G. announced the successful sale of Soleo Health, a Texas-based specialty pharmacy and infusion services provider, to funds managed by Court Square Capital and WindRose Health Investors. The transaction marks a significant exit from a healthcare investment that H.I.G. had transformed from a regional player to a national provider.

Headquartered in Frisco, Texas, Soleo Health delivers personalized healthcare to patients with complex, rare, and ultra-rare medical conditions through its network of 26 pharmacies and more than 30 ambulatory infusion suites across the United States. The company’s specialized nursing network serves patients in all 50 states.

During H.I.G.’s ownership period, the firm implemented a comprehensive growth strategy that included expanding Soleo’s geographical footprint, introducing new clinical models, diversifying payor relationships, and strengthening the management team.

“H.I.G. has been an exceptional partner to Soleo and instrumental in helping us build the Company into the market leader we are today,” said Drew Walk, President and Chief Executive Officer at Soleo. “H.I.G. supported several significant investments in talent and infrastructure, strengthening our ability to reach more patients and provide exceptional care across our network.”

For H.I.G., the sale represents the successful execution of its value-creation playbook in the healthcare sector, an increasingly important focus area for the firm.

“Drew and the Soleo management team have done an outstanding job transforming Soleo from a regional infusion player into a national specialty care provider, with a variety of compelling growth opportunities,” noted Scott Zhu, Managing Director at H.I.G.

Growth equity division gains recognition

Just ten days later, on February 13, H.I.G. announced that its dedicated growth capital investment affiliate, H.I.G. Growth Partners, had been recognized among the Top Growth Equity Firms of 2024 by GrowthCap for the second consecutive year.

The San Francisco-based division specializes in providing growth capital to businesses across North America, Europe, and Latin America, with particular focus on technology, healthcare, internet and media, consumer products, and technology-enabled financial and business services.

GrowthCap, an advisory firm specializing in growth capital, evaluates firms based on sector expertise, investment judgment, demonstrated value creation, senior partner composition, talent retention, and firm momentum.

“At H.I.G. Growth, we take pride in building meaningful partnerships with forward-thinking founders and leadership teams to drive impactful growth,” said Ross Hiatt, Managing Director and Head of H.I.G. Growth. “Leveraging H.I.G. Capital’s broad reach, scale, and over 30 years of experience, we provide unique support and perspectives that empower businesses to scale and thrive.”

The recognition follows other recent accolades for H.I.G. Growth and its team, including “2024 Top Software Investors” and “2024 Top Private Equity Firms.”

Diversified strategy across North America

These February developments showcase H.I.G.’s multifaceted approach to the North American market, balancing successful exits from mature investments while continuing to build its reputation in high-growth sectors.

The firm’s activity in North America extends beyond healthcare and growth equity. In January, H.I.G. acquired Patriot Pickle, a New Jersey-based pickle manufacturer that has already expanded operations with a new facility in Garland, Texas.

Since its founding in 1993, H.I.G. has invested in more than 400 companies worldwide, with its current portfolio including over 100 companies generating combined sales in excess of $53 billion.

With offices in Miami, New York, Boston, Chicago, Los Angeles, San Francisco, and Atlanta, H.I.G. maintains a strong domestic presence while continuing its global expansion across Europe, Latin America, the Middle East, and Asia.

The firm’s seven investment strategies span private equity, growth equity, real estate, direct lending, infrastructure, special situations debt, and growth-stage healthcare, allowing it to deploy capital across the risk spectrum and throughout economic cycles.

Investment analysts note that H.I.G.’s February activities reflect the firm’s disciplined approach to both realizing value from mature investments and identifying new growth opportunities in a competitive North American market.

As private equity firms face increased scrutiny and a challenging dealmaking environment in 2025, H.I.G.’s balanced strategy appears positioned to navigate market uncertainties while continuing to deliver returns across its diverse investment platforms.

DISCLAIMER – “Views Expressed Disclaimer: This article is not financial adviceDue diligence and caution are paramount. Views and opinions expressed are those of the authors and do not reflect the official position of any other author, agency, organization, employer or company, including NEO CYMED PUBLISHING LIMITED, which is the publishing company performing under the name Cyprus-Mail…more